Disease name

선천 레베르 흑암시
 Congenital Leber amaurosis

Marker gene

Gene symbol Chromosome location Protein name
AIPL1 17p13.2 Aryl-hydrocarbon-interacting protein-like 1
CRX 19q13.32 Cone-rod homeobox protein
RPE65 1p31.1 Retinoid isomerohydrolase
CEP290 12q21.32 Centrosomal protein of 290 kDa
CRB1 1q31.3 Crumbs homolog 1
GUCY2D 17p13.1 Retinal guanylyl cyclase 1
IMPDH1 7q32.1 Inosine-5'-monophosphate dehydrogenase 1
LCA5 6q14.1 Lebercilin
LRAT 4q32.1 Lecithin retinol acyltransferase
RD3 1q32.3 Protein RD3
RDH12 14q23.3 Retinol dehydrogenase 12
RPGRIP1 14q11.2 X-linked retinitis pigmentosa GTPase regulator-interacting protein 1
SPATA7 14q31.3 Spermatogenesis-associated protein 7
TULP1 6p21.3 Tubby-related protein 1

Prevalence

1-5 / 10 000

Inheritance

상염색체 우성, 상염색체 열성

Age of onset

신생아기, 영아기

ICD 10 code

H35.5

MIM number

146690
179900
204000
204100
602225
604210
604232
604393
604537
605446
608553
610612
611755
612712
613341
613826
613829
613835
613837
613843

Synonym

Amaurosis congenita of Leber

Summary

Leber congenital amaurosis (LCA) is a retinal dystrophy and/or dysplasia of prenatal onset. About 10 to 20% of blind children are thought to suffer from LCA, which makes it one of the frequent causes of childhood blindness. It is thought to account for 5% of inherited retinal disease. Affected children fail to fix and follow due to little or no retinal sensitivity to visual stimuli. Electroretinography shows either no or very reduced retinal function. Fundus examination in the first months of life is frequently normal, but later chorioretinal atrophy with intraretinal pigment migration becomes apparent. In some patients, a macular punched-out lesion is present. Patients have nystagmus and frequently poke their eyes. LCA is inherited as an autosomal recessive trait in the large majority of patients, with only a limited number of cases with autosomal dominant inheritance described. LCA is genetically heterogeneous, and, to date, mutations have been identified in six different genes known to be associated with LCA: AIPL1, CRB1, CRX, GUCY2D, RPE65 and RPGRIP1. At least another three additional loci have been linked to the condition. Although therapy is not currently available, encouraging results have been obtained with gene therapy in a dog model for this disease.